-20.85 (-1.29%) Sun Pharmaceutical Industries has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its Halol facility in the state of Gujarat, during the period February 12-23, 2018.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.